Galaxy Medicare IPO Details
Issue Date
10 Sep - 12 Sep'25
Price Band
₹51 - ₹54
Lot Size
2000 Shares
IPO Size
₹22.31 Cr
Listing At
NSE
Overall Subscription
1.79x
Galaxy Medicare IPO Listing Details
Listing On
17 Sep'25
Issue Price
₹54
Listed Price
₹ 54
Retail Gain/Listing Gain
--
Schedule of Galaxy Medicare IPO
IPO Open Date
10/09/2025
IPO Close Date
12/09/2025
Basis of Allotment
15/09/2025
Refund Initiation
Credit of Shares
Listing on exchange
17/09/2025
Galaxy Medicare IPO Subscription Status Live
(Last updated on 12 Sep 2025 04:45 PM)
Day | Total | QIB | Retail | NII |
|---|---|---|---|---|
Day 1 10-Sep-2025 | 0.46x | 1x | 0.34x | 0.66x |
Day 2 11-Sep-2025 | 0.85x | 1x | 0.71x | 1.18x |
Day 3 12-Sep-2025 | 1.78x | 1x | 2.08x | 1.61x |
About Galaxy Medicare IPO
The 100% book building issue of Galaxy Medicare Ltd comprises a fresh issue and an offer for sale of up to 33,08,000 and 8,24,000 equity shares, respectively. The price band is ₹51-₹54 per share and the lot size is 2000. The IPO opens on September 10, 2025 and closes on September 12, 2025.
The listing date is on or about September 17, 2025 and the allotment date is on September 15, 2025. The credit of shares to the Demat account will take place on or about September 16, 2025, while the initiation of refund will take place on or before September 16, 2025.
Galaxy Medicare Ltd offers a range of Plaster of Paris Bandages (POP Bandages), medical tapes and bandages, other surgical dressings, and external preparations for wound care and wound management. With a portfolio of 27 registered trademarks in India under various brand names, it caters extensively to both domestic and international markets. Its products are widely accepted by the medical fraternity and are supplied all over India to Central and State Government Health Departments, Corporate Hospitals and private players.
Objectives of Galaxy Medicare IPO
- Funding capital expenditure requirement towards purchase of machinery for its existing manufacturing facility at Bhubaneshwar, Odisha
- Funding the working capital requirements
- General corporate purposes
- Meet offer expenses
Galaxy Medicare IPO Valuation
Detail | Information |
|---|---|
Upper Price Band | ₹54 |
Fresh Issue | Up to 33,08,000 equity shares |
Offer for Sale | Up to 8,24,000 equity shares |
EPS in ₹ for FY 25 | 2.84 |
Galaxy Medicare IPO Lot Size
Application | Lots | Shares | Amount in INR |
|---|---|---|---|
Individual Investors (Retail) (Min) | 2 | 4000 | 2,16,000 |
Individual Investors (Retail) (Max) | 2 | 4000 | 2,16,000 |
S-HNI (Min) | 3 | 6000 | 3,24,000 |
S-HNI (Max) | 9 | 18000 | 9,72,000 |
B-HNI (Min) | 10 | 20000 | 10,80,000 |
Galaxy Medicare IPO Share Offer and Subscription Details
Investor Category | Shares Offered |
|---|---|
QIBs | Not more than 50% of the net offer |
Non-institutional Investors | Not less than 15% of the net offer |
Retail Individual Investors | Not less than 35% of the net offer |
Industry Outlook
The global plaster bandages market size was USD 8.8 billion in 2023 and is projected to reach USD 14.9 billion by 2032, expanding at a CAGR of 5.60% during 2024–2032. The market growth is attributed to the growing demand for effective healing solutions. The Indian medical tapes and bandages market was valued at ₹2,296 crore in 2021 which is expected to reach ₹3,362 crore in 2028 at a CAGR of 5.8%.
Increasing demand for effective wound care solutions is underscoring the importance of plaster bandages. These medical products, which provide support and protection to injured body parts, are a staple in healthcare settings worldwide.
Company Information
Galaxy Medicare Ltd offers a range of Plaster of Paris Bandages (POP Bandages), medical tapes and bandages, other surgical dressings, and external preparations for wound care and wound management. With a portfolio of 27 registered trademarks in India under various brand names, it caters extensively to both domestic and international markets. Its products are widely accepted by the medical fraternity and are supplied all over India to Central and State Government Health Departments, Corporate Hospitals and private players.
The company’s plaster of paris bandage (POP Bandage) and other surgical dressings offer advancements in technology and design, providing improved effectiveness and convenience compared to traditional bandages.
Strengths of Galaxy Medicare IPO
- Organisational stability along with management expertise
- Established reputation and customer relationships
- Focus on consistently meeting quality standards
- International presence
- Well-established manufacturing facility designed for wide range of products
- Experienced management team and a motivated and efficient workforce
Risks of Galaxy Medicare IPO
- Loss of significant customers could have an adverse effect on business
- Shortfall in supply of raw materials could adversely affect operations
- Failure to manage inventory and trade receivables could have an adverse effect on net sales, profitability, cash flow and liquidity
- Proliferation of look-alike products in the market poses a risk on reputation and brand name
- Revenue from exports which are exposed to potential financial, economic, political and other risks of international markets
All Financial Information about Galaxy Medicare
Year | Year Data |
|---|---|
FY25 | 39.202 |
FY24 | 36.151 |
FY23 | 31.205 |
Comparison with peers
Company Name | PAT (in ₹ crores) | EPS (in ₹) | NAV (in ₹ per share) | Return on Net Worth (in %) |
|---|---|---|---|---|
Galaxy Medicare Ltd | 3.3704 | 2.84 | 14.06 | 10.25 |
Adeshwar Meditex Ltd | 2.0657 | 1.43 | 27.69 | 5.17 |
KMS Medisurgi Ltd | 0.4398 | 1.33 | 24.50 | 5.44 |
Anchor Investor Bidding Date
The anchor investor bidding date is September 9, 2025.
IPO Registrar and Book Running Lead Manager
- Registrar: Cameo Corporate Services Ltd
- Book Running Lead Manager: Affinity Global Capital Market Private Limited
Business Model
Galaxy Medicare Ltd is into the manufacturing, trading and exporting of medical devices, plasters of paris bandages (POP Bandage) and other surgical dressings in India. Its business encompasses:
- Manufacturing and branding of its own products under its flagship brands
- OEMs ranging from sourcing of components, designing, manufacturing, quality testing as per the specifications provided by certain brand owners on Principal-to-Principal basis
- Institutional sale to various government department through participation in tenders on platforms like GEM Portal
- Exporting its manufactured product to international markets
- Trading of medical device and other surgical dressings
Company Growth Trajectory
The revenue from operations of Galaxy Medicare Ltd grew from ₹31.2052 crores in FY 23 to ₹39.2016 crores in FY 25. Its operating EBITDA margin grew from 10.05% in FY 23 to 11.69% in FY 25. Organisational stability coupled with established reputation and customer relationships has helped the company grow over the years.
Market Position
Over the years, Galaxy Medicare Ltd has established its presence in India and in international markets by offering a wide range of quality consumer products. With a portfolio of 27 registered trademarks in India under various brand names, the company caters extensively to both domestic and international markets.
Its products are widely accepted by the medical fraternity and are supplied all over India to Central and State Government Health Departments, Corporate Hospitals and private players.
Galaxy Medicare IPO Profit and Loss
Parameter | FY25 | FY24 | FY23 |
|---|---|---|---|
Total Income (in ₹ crores) | 40.2682 | 36.9374 | 32.0290 |
Profit Before Tax (in ₹ crores) | 4.5336 | 4.7260 | 2.0028 |
Profit/(loss) After Tax for the Year (in ₹ crores) | 3.3704 | 3.7074 | 1.5714 |
EBITDA (in ₹ crores) | 4.5842 | 5.2631 | 3.1353 |
EPS in ₹ | 2.84 | 3.12 | 1.32 |
Galaxy Medicare IPO Balance Sheet
Parameter | FY25 | FY24 | FY23 |
|---|---|---|---|
Profit/(loss) After Tax for the Year (in ₹ crores) | 3.3704 | 3.7074 | 1.5714 |
Net Cash Flow From / (Used in) Operating Activities (in ₹ crores) | 4.4555 | 2.7084 | 3.6527 |
Net Cash Flow From / (Used in) Investing Activities (in ₹ crores) | 0.3224 | (0.6537) | (1.9137) |
Net Cash Flow From / (Used in) Financing Activities (in ₹ crores) | (4.7190) | (2.0798) | (1.8040) |
Total Cash and Cash Equivalents (in ₹ crores) | 0.1327 | 0.0439 | 0.0690 |
How to Check Allotment Status of Galaxy Medicare IPO?
1. Visit the Registrar’s Website
Visit the website of Cameo Corporate Services and click on any one of the links under IPO Status Links. Choose the Name of the Company from the dropdown. Enter your PAN number, Application number or DP Client ID. Enter Captcha and click on Submit to know the allotment status.
2. Verify on the National Stock Exchange Website
The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Galaxy Medicare Ltd IPO. Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.
On the NSE IPO Bid Verification page, enter:
- Company name from dropdown
- Application number
- PAN Then click 'Submit' to know the allotment status.
How to Apply for Galaxy Medicare Ltd IPO?
- Log in to your Kotak Neo Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
- Specify IPO details - Enter the number of lots and the price you wish to apply for.
- Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
- Mandate Notification - Your UPI app will receive a mandate notification to block funds.
- Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.
Galaxy Medicare IPO FAQs
The Galaxy Medicare IPO opens for subscription from 10-09-2025 to 12-09-2025, with a total issue size of ₹22.31 Cr. The IPO price band is ₹51 to ₹54 per share with a lot size of 2000. The company aims to list the shares on BSE & NSE on 17-09-2025.
The Galaxy Medicare IPO will open for subscription on 10-09-2025 and will close on 12-09-2025 for investors.
The lot size of Galaxy Medicare IPO is 2000 equity shares, requiring a minimum investment of ₹108000/2 Lots for retail investors applying in the IPO.
The price band of the Galaxy Medicare IPO has been fixed at ₹51 to ₹54 per equity share.
You can apply for the Galaxy Medicare IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.
Galaxy Medicare IPO allotment will take place on 15-09-2025.
You can check the Galaxy Medicare IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.
Galaxy Medicare shares will list on the stock exchanges on 17-09-2025.
You can find detailed information about the Galaxy Medicare IPO, including its business operations, financial performance, risk factors, and IPO objectives, in the Draft or Red Herring Prospectus (RHP).
Galaxy Medicare Ltd’s IPO consists of a fresh issue of up to 33,08,000 equity shares aggregating up to ₹16.74 crores and an offer for sale of up to 8,24,000 equity shares aggregating to ₹4.45 crores. The total offer size combines both components and is up to 41,32,000 equity shares aggregating to ₹22.31 crore.
The IPO will open on September 10, 2025 and will close on September 12, 2025.
Dillip Kumar Das is the chairman and MD of Galaxy Medicare Ltd.
The lot size of shares in the Galaxy Medicare Ltd IPO is 2000
You can read more about the IPO of Galaxy Medicare Ltd from the company red herring prospectus here.
Related News
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Neo Research Team, nor is it a report published by the Kotak Neo Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.









